Literature DB >> 19470832

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia.

Sonia Ramamoorthy1, Michael Donohue, Martina Buck.   

Abstract

Muscle wasting is a critical feature of patients afflicted by acquired immune deficiency syndrome (AIDS), cancer, or chronic inflammatory diseases. In a mouse model of muscle wasting, TNF-alpha induces oxidative stress and nitric oxide synthase-2 (NOS2) and decreases myogenin, Jun-D, and creatinine kinase muscle isoform (CKM) expression. Here, we studied 12 patients with muscle wasting due to cancer (N = 10) or AIDS (N = 2) and 4 control subjects. We show that in skeletal muscle of cachectic patients there is 1) increased expression and activity of the TNF-alpha signaling, including TNF-alpha mRNA, activation of TNFR1, and TNF-alpha-associated to TNFR1; 2) increased oxidative stress, as determined by the presence of malondialdehyde-lysine adducts; 3) increased NOS2 mRNA and protein; 4) decreased expression of Jun-D, myogenin, myosin, and CKM mRNA and protein; 5) impaired CKM-E box binding activities, associated with decreased Jun-D/myogenin activities; and 6) oxidative modification and ubiquitination of Jun-D. These studies show that these molecular pathways are modulated in association with muscle wasting in patients with cancer or AIDS, and whether or not they cause muscle wasting remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470832      PMCID: PMC2724118          DOI: 10.1152/ajpendo.90529.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  38 in total

1.  Biomedicine. Protein loss in cancer cachexia.

Authors:  M J Tisdale
Journal:  Science       Date:  2000-09-29       Impact factor: 47.728

2.  Impaired voluntary running capacity of creatine kinase-deficient mice.

Authors:  Iman Momken; Patrick Lechêne; Nathalie Koulmann; Dominique Fortin; Philippe Mateo; Bich Thuy Doan; Jacqueline Hoerter; Xavier Bigard; Vladimir Veksler; Renée Ventura-Clapier
Journal:  J Physiol       Date:  2005-04-14       Impact factor: 5.182

3.  Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha.

Authors:  M Buck; L Zhang; N A Halasz; T Hunter; M Chojkier
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

4.  Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.

Authors:  K J Tracey; S Morgello; B Koplin; T J Fahey; J Fox; A Aledo; K R Manogue; A Cerami
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

5.  Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.

Authors:  K Houglum; M Filip; J L Witztum; M Chojkier
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression.

Authors:  K S Lee; M Buck; K Houglum; M Chojkier
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.

Authors:  T Henkel; T Machleidt; I Alkalay; M Krönke; Y Ben-Neriah; P A Baeuerle
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

8.  Characterization of a cancer cachectic factor.

Authors:  P Todorov; P Cariuk; T McDevitt; B Coles; K Fearon; M Tisdale
Journal:  Nature       Date:  1996-02-22       Impact factor: 49.962

9.  Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.

Authors:  Florian L Muller; Wook Song; Youngmok C Jang; Yuhong Liu; Marian Sabia; Arlan Richardson; Holly Van Remmen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-06-20       Impact factor: 3.619

10.  A ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis.

Authors:  Martina Buck; Mario Chojkier
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

View more
  26 in total

Review 1.  Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.

Authors:  Subash C Gupta; Ji Hye Kim; Ramaswamy Kannappan; Simone Reuter; Patrick M Dougherty; Bharat B Aggarwal
Journal:  Exp Biol Med (Maywood)       Date:  2011-05-12

2.  Molecular mechanisms underlying skeletal muscle weakness in human cancer: reduced myosin-actin cross-bridge formation and kinetics.

Authors:  Michael J Toth; Mark S Miller; Damien M Callahan; Andrew P Sweeny; Ivette Nunez; Steven M Grunberg; Hirak Der-Torossian; Marion E Couch; Kim Dittus
Journal:  J Appl Physiol (1985)       Date:  2013-02-14

Review 3.  Reactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases.

Authors:  Lucia M Leitner; Rebecca J Wilson; Zhen Yan; Axel Gödecke
Journal:  Antioxid Redox Signal       Date:  2017-01-04       Impact factor: 8.401

Review 4.  Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.

Authors:  Erin E Talbert; Denis C Guttridge
Journal:  Semin Cell Dev Biol       Date:  2015-09-16       Impact factor: 7.727

5.  An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression during Satellite Cell Differentiation, and Its Activity Is Suppressed in Congestive Heart Failure.

Authors:  Tadashi Yoshida; Patrice Delafontaine
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

6.  Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.

Authors:  Fabio Penna; Domiziana Costamagna; Alessandro Fanzani; Gabriella Bonelli; Francesco M Baccino; Paola Costelli
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

7.  Muscle disuse alters skeletal muscle contractile function at the molecular and cellular levels in older adult humans in a sex-specific manner.

Authors:  Damien M Callahan; Mark S Miller; Andrew P Sweeny; Timothy W Tourville; James R Slauterbeck; Patrick D Savage; David W Maugan; Philip A Ades; Bruce D Beynnon; Michael J Toth
Journal:  J Physiol       Date:  2014-07-18       Impact factor: 5.182

8.  Molecular characterization of argininosuccinate synthase and argininosuccinate lyase from the liver of the African lungfish Protopterus annectens, and their mRNA expression levels in the liver, kidney, brain and skeletal muscle during aestivation.

Authors:  You R Chng; Jasmine L Y Ong; Biyun Ching; Xiu L Chen; Wai P Wong; Shit F Chew; Yuen K Ip
Journal:  J Comp Physiol B       Date:  2014-07-18       Impact factor: 2.200

9.  Molecular and cellular mechanisms of skeletal muscle atrophy: an update.

Authors:  Alessandro Fanzani; Viviane M Conraads; Fabio Penna; Wim Martinet
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-06-07       Impact factor: 12.910

10.  Pharmacological or genetic inhibition of iNOS prevents cachexia-mediated muscle wasting and its associated metabolism defects.

Authors:  Jason Sadek; Derek T Hall; Bianca Colalillo; Amr Omer; Anne-Marie K Tremblay; Virginie Sanguin-Gendreau; William Muller; Sergio Di Marco; Marco Emilio Bianchi; Imed-Eddine Gallouzi
Journal:  EMBO Mol Med       Date:  2021-06-07       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.